Orgyn Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 22 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.69 M
as on 19-12-2024
- Revenue 105.81%
(FY 2022)
- Profit 201.94%
(FY 2022)
- Ebitda 22.47%
(FY 2022)
- Net Worth 23.79%
(FY 2022)
- Total Assets 8.36%
(FY 2022)
About Orgyn Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.69 M.
Meeta Bhatia and Sunil Bhatia serve as directors at the Company.
- CIN/LLPIN
U51397DL2002PTC115595
- Company No.
115595
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2002
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Orgyn Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Bhatia  | Director | 13-May-2002 | Current |
| Meeta Bhatia | Director | 13-May-2002 | Current |
Financial Performance of Orgyn Laboratories.
Orgyn Laboratories Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 105.81% increase. The company also saw a substantial improvement in profitability, with a 201.94% increase in profit. The company's net worth Soared by an impressive increase of 23.79%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orgyn Laboratories?
In 2022, Orgyn Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 31 May 2024 | ₹2.69 M | Open |
How Many Employees Work at Orgyn Laboratories?
Orgyn Laboratories has a workforce of 11 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orgyn Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orgyn Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
